SlideShare a Scribd company logo
Implications of Tay-Sachs
Disease: A Case Study for
Public Knowledge
By: Adam Green
Wake Forest University
Department of Biology
What am I doing?

 My goals are to explain:
 What is Tay-Sachs Disease?
What am I doing?

 My goals are to explain:
 What is Tay-Sachs Disease
 How is it determined?
What I am doing?

 My goals are to explain:
 What is Tay-Sachs Disease
 How is it determined?

 Who can have it and how lethal is it?
What am I doing?

 My goals are to explain:
 What is Tay-Sachs Disease
 How is it determined?
 Who can have it and how lethal is it?
 What are the treatment options?
What am I doing?

 My goals are to explain:
 What is Tay-Sachs Disease
 How is it determined?
 Who can have it and how lethal is it?

 What are the treatment options?
 How can it be prevented?
Patient Case Study and Ethics

 Afterwards, I will present a mock patient case study and
an ethical dilemma.
Interactive Quiz Bowl

 At the end of each section, there will be quiz questions.
Interactive Quiz Bowl

 You will work in teams and you will have two minutes to
answer each question.
Note of Warning

 Before Beginning:
 You should have a competent understanding of DNA,
RNA, and the Central Dogma
Note of Warning

 Before Beginning:
 You should have a competent understanding of DNA,
RNA, and the Central Dogma
 Genes and the types of mutations
Notes of Warning

 Before Beginning:
 You should have a competent understanding of DNA,
RNA, and the Central Dogma
 Genes and the types of mutations
 The endomembrane system
Note of warning

 Before Beginning:
 You should have a competent understanding of DNA,
RNA, and the Central Dogma
 Genes and the types of mutations

 The endomembrane system
 The Plasma Membrane
Notes of Warning
 Before Beginning:
 You should have a competent understanding of DNA,
RNA, and the Central Dogma
 Genes and the types of mutations
 The endomembrane system
 Plasma Membrane
 Here are some helpful links:
 http://www.ncbi.nlm.nih.gov/Class/MLACourse/Modules/
MolBioReview/slide_list.html
 http://www.youtube.com/watch?v=UAaTEjYmxso
 http://en.wikipedia.org/wiki/Cell_membrane
Let’s Begin!

 Please spilt into teams
What is TaySachs Disease
It is a lysosomal storage
disorder due to genetic
mutations in the HEX A gene.
What is TaySachs Disease?
• One common mutation is a 4
base insertion in the HEX A
gene.
What is TaySachs?
As we know, this could change
how the RNA is transcribed and
the resultant protein.
What is TaySachs Disease?
And in fact, it does change the
protein. The HEX A gene is
responsible for the production
of an enzyme(protein) called βhexsaminidase A that is
responsible for breaking down
fatty substances called GM2
gangliosides that can
accumulate in our brains and
spinal cords.
What is TaySachs Disease?
These enzymes(proteins) are
made on ribosomes attached to
the rough ER and sent to
lysosomes that act as recycling
centers to break down toxic
substances such as fatty
substances called GM2Gangliosidies that accumulate
in our nervous system.
Often lack of function of these
enzymes results in death.
What is TaySachs Disease?
GM2 gangliosides contain a long
hydrophobic tail that inserts
itself into the plasma
membrane of ganglion cells in
neurons surrounding the retina
of our eyes.

Pictures: (top) Hexsaminidase
with both alpha and beta
subunits. Only the alpha
subunit is involved in Tay-Sachs
Disease. (bottom) is a depiction
of a GM2-ganglioside.
What is TaySachs Disease?
They also contain acidic groups
called head groups that stick
above the plasma membrane
and can be involved in cell-cell
recognition as a result.
While the exact function of GM2
Gangliosides is unknown, it has
been suspected that they serve
as an intermediate in the
synthesis of more complex
gangliosides needed for normal
brain development.
What is TaySachs Disease?
This would explain why the
enzyme HEX A cleaves part of
the ganglioside and the
absence of this enzyme results
in improper brain development
often culminating in death.
What is TaySachs Disease?
On another note, this disease is
known as an autosomal
recessive disorder
What is TaySachs Disease?
An autosomal recessive
disorder means that the
mutation in the HEXA gene
exists in two alleles. Alleles are
alternative form of a gene.
Humans contain two sets of
genes, one from their
mother, and one from their
father. The offspring must have
two alleles, one from the
mother and the father, in order
for the disease to be expressed.
What is TaySachs Disease?
The actual enzyme activity
required by β-hexosaminidase
is very small in order to
sufficiently break down GM2gangliosides. Thus, some
individuals may only have one
mutant copy of the HEXA gene.
These individuals will have
abnormally low enzyme activity
levels, but still enough to break
down fatty substances in your
nervous system.
They are called heterozygous
carriers.
What is TaySachs Disease?
If two of these heterozygous
carriers with abnormal enzyme
levels mate, they have a 25%
chance of having a child
affected with Tay-Sachs
Disease. This would mean that
each parent has 1 mutant copy
out of two (1/2) and the child
has both copies; thus the
probability is ½ x ½ = ¼ or
25% that the child will be
affected.
This is the basis for a recessive
disorder.
We see in this family tree, the
offspring ratio is 3:1 and 25%
chance of being affected.
What is TaySachs Disease
We can also illustrate this
concept through a punnett
square. Lets represent A as the
normal HEX A allele(alternative
form of gene) and a as the
mutant allele that produces
abnormal HEX A enzyme levels.
What is TaySachs Disease?
As you can see, when you cross
two heterozygotes, you get a
25% chance of being affected.
What is TaySachs Disease?
Now, to further complicate
matters, it is important to
realize that more than 120
mutations have been found in
the HEX A gene.
These mutations vary in the
amount of β-hexosaminidase
they produce and thus lead to
less severe forms of the
disease.
What is TaySachs Disease
This leads to two subtypes of
Tay- Sachs Disease:
1) Early-onset Infantile: the
child possesses two mutant
copies of the HEX A and
produces no functional
enzyme. This the most
severe.
What is TaySachs Disease?
This leads to two subtypes TaySachs Disease:
1) Early-onset Infantile: the
child possesses two mutant
copies of the HEX A and
produces none of the
functional enzyme. This the
most severe.
2) Late – onset adult: disease
caused at times by
compound heterozygosity
that I will explain later.
Patient has abnormal
enzyme levels resulting in
late-onset disease.

The images present a young
child with Tay-Sachs and an
adult with Tay-Sachs
Time for Quiz Questions!!

 Ready your teams!
Quiz Question 1
 The following Base Sequence is the normal gene
sequence: AGTCGTTAACCAG
 Although the above sequence is not the HEX A gene,
what mutational sequence below could be analogous to
Tay-Sachs?
 A. AGTCGTTCAACCAG

 B. AGTCGTTCCAACCAG
 C. AGTCGTTCCGGAACCAG
 D. : AGTCGTTAACCAG
Quiz Question 1

 Time’s up!
 Report your answers
Quiz Question 1
 The following Base Sequence is the normal gene sequence:
AGTCGTTAACCAG
 Although the above sequence is not the HEX A gene, what
mutational sequence below could be analogous to TaySachs?

 A. AGTCGTTCAACCAG
 B. AGTCGTTCCAACCAG
 C. AGTCGTTCCGGAACCAG
 D. : AGTCGTTAACCAG
THE ANSWER is C. A common mutation found in the HEX A
gene can result from a 4 base pair insertion! Give yourself 2
points if you got it right. But note, that other mutations are
also possible.
Quiz Question 2

 Brace yourselves!
Quiz Question 2
 If a male contains one mutant allele for the HEX A gene
(Aa) and the female contains two normal alleles(AA),
then what is the chance that they will have an offspring
with Tay-Sachs? Hint: Draw a Punnett Square.
 A. 75%
 B. 60%
 C. 25%
 D. None of the above
Quiz Question 2

 Time’s up!
 Report your Answers!
Quiz Question 2
 If a male contains one mutant allele for the HEX A gene
(Aa) and the female contains two normal
alleles(AA), then what is the chance that they will have
an offspring with Tay-Sachs? Hint: Draw a Punnett
Square.
 A. 75%
 B. 60%
 C. 25%
 D. None of the above
THE ANSWER IS D. Tay-Sachs is a recessive disorder
meaning that the offspring has to have two mutant alleles.
Only one mutant allele is available. The answer should be
0%.
Question 2: mathematics
explained
Here is an example of how this problem could be solved.
 1) Make a punnett square.

A
A

AA

AA

a


A

Aa

Aa

2)Perform data analysis. For example, we can say that 2/4 of the
offspring or 50% will be heterozygous carriers. The remaining 50%
will be homozygous dominant; thus, since there are no homozygous
recessive offspring, we can say there is a 0% probability of the
offspring having a recessive disease such as Tay- Sachs.
Quiz Question 3

 Brace yourselves!
Question 3

 The following blood test was conducted on a patient. The
lab found his β-hexosaminidase levels to be operating at
15%. This means that 15% of the enzymes were
functioning normally. Can we conclude the patient has
Tay-Sachs?
 A. Yes
 B. No
 C. Not sure yet.
Question 3

 Time is up!
 Report your answers
Question 3
 The following blood test was conducted on a patient. The
lab found his β-hexosaminidase levels to be operating at
15%. This means that 15% of the enzymes were
functioning normally. Can we conclude the patient has
Tay-Sachs?
 A. Yes
 B. No
 C. Not sure yet.

 THE ANSWER IS B. Remember that the enzyme only
requires small amounts to function normally. This also
ties in to our discussion about different mutations
producing different activity levels. We will discuss more
about “critical thresholds” in the next section.
Tally your scores

 Tally your points. The maximum score is 6 and the
minimum score is 0.
How is TaySachs Disease
determined?
Now that we know what this
disease is. We need to know
how is it determined in the lab.
How is TaySachs
Determined?
Tay-Sachs is primarily
determined by a blood test. An
individual with a family history
of Tay-Sachs can consult their
physician and receive a simple
blood test that measures βhexosaminidase levels.
How is TaySachs Disease
Determined?
Remember Quiz Question 3?
Well, it turns out that
individuals affected with TaySachs Disease have between
0% activity to 10% activity.
Infantile Tay-Sachs patients
have 0%. Adult patients have
an activity level between 510% to produce symptoms.
Any amount greater than 10%
will result in no symptoms.
How is TaySachs
Determined?
Individuals with blood levels at
or below this “critical threshold
possess visible symptoms such
as:
How is TaySachs Disease
Determined?
Individuals with blood levels at
or below this “critical threshold
possess visible symptoms such
as:
1) Cherry red- spot: results
from the accumulation of GM2gangliosides that can block
blood supply, disrupt a patient’s
vision, and inhibit normal brain
development. Prime indicator of
Tay-Sachs.
How is TaySachs Disease
Determined?
Individuals with blood levels at
or below this “critical threshold
possess visible symptoms such
as:
1) Cherry red- spot: results
from the accumulation of GM2gangliosides that can block
blood supply and disrupt a
patient’s vision. Prime indicator
of Tay-Sachs.
2) In children, symptoms arise
within 3 to 6 months. Children
lose motor skills such as the
ability to crawl.
How is TaySachs Disease
Determined?
Individuals with blood levels at
or below this “critical threshold
possess visible symptoms such
as:
1) Cherry red- spot: results
from the accumulation of GM2gangliosides lipids that can
block blood supply and disrupt
a patient’s vision. Prime
indicator of Tay-Sachs.
2) In children, symptoms arise
within 3 to six months.
Children lose motor skills such
as the ability to crawl.
3) Eventually, affected
individuals can experience
seizures, paralysis, and loss of
intellectual abilities due to their
nerve cells dying.
How is TaySachs Disease
Determined?
Individuals with blood levels at or
below this “critical threshold
possess visible symptoms such as:
1) Cherry red- spot: results from
the accumulation of GM2gangliosides lipids that can block
blood supply and disrupt a
patient’s vision. Prime indicator of
Tay-Sachs.
2) In children, symptoms arise
within 3 to six months. Children
lose motor skills such as the ability
to crawl.
3) Eventually, affected individuals
can experience seizures, paralysis,
and loss of intellectual abilities due
to their nerve cells dying.
4) Microscopic Analysis can also
find the retinal neurons to be
bloated from excess ganglioside
storage.

Pictures: The top image represents bloated
retinal neurons from excess ganglioside storage
due to hexosaminidase deficiency.
How is TaySachs
Determined?
My next concern is how can a
mutation or mutations in the
Hex A gene be determined?
How is TaySachs
Determined?
The answer can be solved
through three related
methodologies:
1) PCR
How is TaySachs Disease
Determined?
The Answer can be solved
through three related
methodologies:
1) PCR
2) Gel Electrophoresis
How is TaySachs Disease
Determined?
The Answer can be solved
through three related
methodologies:
1) PCR
2) Gel Electrophoresis
3) DNA Sequencing
How is TaySachs Disease
Determined?
PCR stands for polymerase
chain reaction. This is done to
amplify a specific segment of a
chromosome such as the HEX
A gene or even a specific
segment of the Hex A gene.
The process can occur in 4 easy
steps:
How is TaySachs Disease
Determined?
PCR stands for polymerase
chain reaction. This is done to
amplify a specific segment of a
chromosome such as the HEX
A gene or even a specific
segment of the Hex A gene.
The process can occur in 4 easy
steps:
1) RNA isolation: You have to
isolate the RNA from your
sample and covert it back to
DNA using enzymes known as
reverse transcriptases. This
allows you to only amplify the
region that is expressed.
How is TaySachs
Determined?
PCR stands for polymerase
chain reaction. This is done to
amplify a specific segment of a
chromosome such as the HEX
A gene or even a specific
segment of the Hex A gene.
The process can occur in 4 easy
steps:
1) RNA isolation: You have to
isolate the RNA from your
sample and covert it back to
DNA using enzymes known
as reverse transcriptases.
This allows you to only
amplify the region that is
expressed.
2) You then apply heat to your
DNA to pull the strands
apart.
How is TaySachs
Determined?
PCR stands for polymerase
chain reaction. This is done to
amplify a specific segment of a
chromosome such as the HEX
A gene or even a specific
segment of the Hex A gene.
The process can occur in 4 easy
steps:
3) Anneal primers: attach
thermostable DNA sequences to
your DNA to begin the process
of amplification
How is TaySachs
Determined?
PCR stands for polymerase
chain reaction. This is done to
amplify a specific segment of a
chromosome such as the HEX
A gene or even a specific
segment of the Hex A gene.
The process can occur in 4 easy
steps:
3) Anneal primers: attach
thermostable base DNA
sequence to your DNA to begin
the process of amplification
4) Add a thermostable
polymerase to attach to your
primers and begin replication.
How is TaySachs
Determined?
PCR stands for polymerase
chain reaction. This is done to
amplify a specific segment of a
chromosome such as the HEX
A gene or even a specific
segment of the Hex A gene.
The process can occur in 4 easy
steps:
3) Anneal primers: attach
thermostable base DNA
sequence to your DNA to begin
the process of amplification
4) Add a thermostable
polymerase to attach to your
primers and begin replication
5) Repeat to desired
amplification.
Picture: Diagram explaining
PCR.
How is TaySachs
Determined?
Now that you amplified DNA,
you can place it on a gel and
run an electric field through
your DNA segment. The
amplified DNA will show up on
the gel and move along the gel
against the negative electrode
since DNA contains negatively
charged phosphate groups.
How is TaySachs
Determined?
Mutant Hex A can be the result
of a 4 base pair insertion; thus,
it would have more phosphate
groups and move less along the
gel than a normal HEX A DNA
due to larger molecules getting
stuck in the gel. Think of the
gel as a sieve.

The following picture is an
example of data from a gel
electrophoresis experiment.
Smaller DNA fragments move
farther than larger DNA
fragments.
How is TaySachs
Determined?
Since Tay-Sachs is caused by
mutations, you can sequence
the HEX A gene of a normal
individual and an affected
individual and see the DNA
change. This is done in two
ways: Sanger Sequencing and
Cycle Sequencing via primers.
Attached are two videos to
watch that explains it in more
detail:

1) http://www.dnalc.org/resour
ces/animations/sangerseq.ht
ml
2) http://www.dnalc.org/view/1
5923-Cycle-sequencing.html
Picture on right depicts Fred
Sanger who developed Sanger
Sequencing. He recently died at
the age of 95.
QUIZ TIME!!

 Now that you understand how mutations in the HEX A
gene can be determined, you can answer these
questions! Ready your troops!
Quiz Question 4:
 A mother reports to her physician that her 4 month year
old just sits in one place for hours with no movement.
She has to be the one to move him at all times. She
suspects he may be paralyzed. What should the doctor
suggest first in his/her diagnosis?
 A. Look for observational clues such as a cherry red spot
 B. Perform a Microscopy Analysis to search for distended
neurons
 C. Order a blood test to look for decreased βhexosaminidase activity levels.
 D. Nothing. The woman is just a paranoid new mother.
Question 4

 Time’s up!!
 Report your Answers!!
Question 4
 A mother reports to her physician that her 4 month year old just sits
in one place for hours with no movement. She has to be the one to
move him at all times. She suspects he may be paralyzed. What
should the doctor suggest first in his diagnosis?
 A. Look for observational clues such as a cherry red spot
 B. Perform a Microscopy Analysis to search for distended neurons
 C. Order a blood test to look for decreased β-hexosaminidase
activity levels.
 D. Nothing. The woman is just a paranoid new mother.
 THE ANSWER IS A. While B and C are also possible, A is a
prime indicator of Tay-Sachs and is the easiest and probably
most convenient way to confirm Tay-Sachs.
Quiz Question 5

 Brace yourselves!!
Question 5

 What feature of DNA structure dictates our rationale that
HEX A mutants with base pair insertions will result in
shorter distances along a gel?
 A. Phosphate groups.
 B. Sugar groups

 C. Base pairs.
 D. acridine ligands
Question 5

 Time’s up!
 Report your Answers!
Question 5
 What feature of DNA structure dictates our rationale that
HEX A mutants with base pair insertions will have
shorter distances along a gel?

 A. Phosphate groups.
 B. Sugar groups
 C. Base pairs.
 D. acridine ligands

 THE ANSWER IS A. While The phosphates in the
DNA backbone contain a negatively charged
oxygen that cause the DNA to repel against the
negative charged electrode, larger DNA fragments
get stuck in the gel more than smaller fragments
and thus move less.
Tally your scores!

 The most points awarded up to this point are 10 points(2
points per question).
 The least points awarded are 0 points 
How lethal is
this disease?
Now that we understand what
Tay-Sachs disease is and how it
can be determined, we still
need to understand one other
factor before we can do a
patient case study. This last
factor is lethality.
How lethal is
this disease?
The most common form of TaySachs disease is infantile TaySachs. Symptoms normally
appear around 3 to 6 months.
The maximum longevity is
sadly only about 4 years or
simply a brief extent into early
childhood.
How lethal is
this disease?
Adult onset disease is more
variable depending on the
mutation and actual amount of
β-hexosaminidase activity
present in the cell.
How lethal is
this disease?
Another factor for adult onset
Tay-Sachs disease is the issue
of compound heterozygosity
that I mentioned previously.
How lethal is
this disease?
Compound Heterozygosity is
just weird. It occurs when an
individual has two recessive
allele mutations in the HEX A
gene at different locations in
the genome. This is indicative
of the fact that there are over
120 mutations found in the HEX
A gene. This can contribute to
adult onset Tay-Sachs as a
result.
How lethal is
this disease?
Another aspect of lethality is
the prevalence.
According to recent studies, 1
out of every 300 people in the
population is a heterozygous
carrier for Tay-Sachs disease.
However, for individuals who
belong to a certain ethnic group
known as the Ashkenazi Jews,
the prevalence increases from 1
in 300 people to 1 in 30 people
who will be a heterozygous
carrier.

Picture on the right depicts
women of Ashkenazi Jewish
heritage. They are genetically
European.
How lethal is
this disease?
The reason why the ratio is so
much greater for Ashkenazi
Jews is likely due to geographic
distributions. A paper published
in the American Journal of
Human Genetics found the
frequency of the HEX A
mutation to be greater in
geographically isolated regions
with the highest frequencies in
countries such as Russia,
Lithuania, and other central and
eastern European countries
where the Ashkenazi Jews
originated. As a result, the ratio
is likely just bad luck.

Figure. The geographic
locations of the Ashkenazi Jews
located in western and eastern
Europe including Russia.

Russia
Quiz Time!!

 Brace yourselves!!
Quiz Question 6
 Which of the following pieces of evidence favors random
“bad luck” for the HEX A mutation in the Ashkenazi
Jewish population?
 A. The ratio for a carrier is 1 out of 30 instead of 1 out of
300.
 B. High mutation frequency in one location and no
frequnecy in other locations.

 C. Heterozygous carriers are capable of producing subnormal enzyme activity levels to prevent symptoms from
appearing.
 D. Some mutations in the HEX A are more deadly than
others.
Quiz Question 6

 Time’s up!!!
 Report your Answers!
Quiz Question 6
 Which of the following pieces of evidence favor random
founder effects over heterozygous advantage for the HEX A
mutation in the Ashkenazi Jewish population?

 A. The ratio for a carrier is 1 out of 30 instead of 1 out of
300.
 B. High mutation frequency in one location and no
frequency in other locations.
 C. Heterozygous carriers are capable of producing subnormal enzyme activity levels to prevent symptoms from
appearing.
 D. Some mutations in the HEX A are more deadly than
others.
 THE ANSWER IS B. Random founder effects occur
from genetic breeding/sampling in isolated
populations over long timespans.
Case Study of Alex

 Now that you understand the basis of Tay-Sachs Disease
 We can examine a mock case study.
 Let’s begin
Meet Alex

 Alex, short for Alexander, is from Russia with two
Russian parents. They are part of the Ashkenazi Jewish
heritage.
Meet Alex

 Alex, short for Alexander, is from Russia with two
Russian parents. They are part of the Ashkenazi Jewish
heritage.
 He is 3 months old.
Meet Alex

 Alex, short for Alexander, is from Russia with two
Russian parents. They are part of the Ashkenazi Jewish
heritage.
 He is 3 months old.
 Alex is the first child of his parents.
Meet Alex

 Alex, short for Alexander, is from Russia with two
Russian parents. They are part of the Ashkenazi Jewish
heritage.
 Alex is 3 months old.
 Alex is the first child of his parents
 A physician observed an eye abnormality called a cherry
red spot through a simple eye examination.
Quiz Question 7

 Brace yourselves!
Quiz Question 7

 What should the doctor order based on these
evaluations?
 A. blood test to measure α-hexosaminidase levels.
 B. motor skills test.

 C. Microscopy analysis of bloated nerve cells.
 D. blood test to measure β- hexosaminidase levels.
Quiz Question 7

 Time’s up!
 Report your Answers!
Quiz Question 7
 What should the doctor order based on these
evaluations?
 A. blood test to measure α-hexosaminidase levels.
 B. motor skills test.
 C. Microscopy analysis of bloated nerve cells.
 D. blood test to measure β- hexosaminidase levels.
 THE BEST ANSWER IS D. Currently, the evidence is
strong for Tay-Sachs Disease, but we need to see if the
enzyme activity levels are below the “critical threshold”
levels.
Tally your scores!

 The maximum points possible are now 14 points.
Alex

 The Blood test results are in and the enzyme activity
levels are immeasurable which indicates infantile TaySachs Disease.
Quiz Question 8

 Brace yourselves!
Quiz Question 8

 What should the doctor’s next recommendation be?
A. Order the lab to characterize the mutation through PCR
and gel electrophoresis
B. Nothing. The blood test is enough evidence.

C. Contact a genetic counselor
D. Re-run the blood test to confirm accuracy.
Quiz Question 8

 Time’s up!
 Report your answers
Quiz Question 8
 What should the doctor’s next recommendation be?
A. Order the lab to characterize the mutation through
PCR and gel electrophoresis
B. Nothing. The blood test is enough evidence.
C. Contact a genetic counselor
D. Re-run the blood test to confirm accuracy.
THE ANSWER IS A. While one blood test is good
evidence, it does not tell us anything about the
genetics of the individual. Thus, it does not inform us
if a mutation is actually present.
Quiz Question 9

 The results are in:
Quiz Question 9

 The results are in:
 PCR and gel electrophoresis confirm shorter PCR
products indicating a base insertion.
Quiz Question 9

 The results are in:
 PCR and gel electrophoresis confirm shorter PCR
products indicating a base insertion.
 DNA Sequencing confirms a 4 base addition for the HEX
A gene.
Quiz Question 8

 The results are in:
 PCR and gel electrophoresis confirm shorter PCR
products indicating a base insertion.
 DNA Sequencing confirms a 4 base addition for the HEX
A gene.

 This agrees with the blood test and observational clues
to confirm Tay-Sachs Disease.
Quiz Question 9

 Now Brace yourselves!
Quiz Question 9
What are the possible treatment options given this new
diagnosis?
A. Gene therapy approaches that engineer viruses which
will turn the nerve cells into “micro factories” that
produce β-hexosaminidase.
B. Developing synthetic chaperones that guide the βhexosaminidase to fold into its native 3D structure.

C. Replace the β-hexsaminidase enzyme just like diabetics
undergo insulin replacement.
D. Use alternative enzymes that catabolize GM2gangliosides
Quiz Question 9

 Time’s up
 Report your answers!
Quiz Question 9
Patient X

=

 The correct answer is none of
the above. All of the answer
choices exhibit examples of
positive research results, but
they are all still a long away
from actual clinical treatment.
So for now, Tay-Sachs
disease, in particular the
more common Infantile TaySachs Disease is a genetic
death sentence that will shut
down a child’s nervous
system before he/she
reaches kindergarden.
Quiz Question 9

 As a result, when it comes to Tay-Sachs Disease,
especially infantile Tay-Sachs, no one is a winner and
that’s why no points are awarded for this question.
Quiz Question 9

 As a result, when it comes to Tay-Sachs
Disease, especially infantile Tay-Sachs, no one is a
winner and that’s why no points are awarded for this
question.

 Since Alex is afflicted with this disease, he will die and
his parents will be left childless.
Can this disease be prevented or
minimized?

 1) Pre-natal genetic diagnosis: The parents can be
tested to see if they are carriers and if their offspring is
carrying both recessive alleles within 10 to 14 weeks.
The parents could then opt for abortion.
Can this disease be prevented or
minimized?
 1) Pre-natal genetic diagnosis: The parents can be
tested to see if they are carrier and if their offspring is
carrying both recessive alleles within 10 to 14 weeks.
The parents could then opt for abortion.
 2) Pre-implantation diagnosis: during in vitro
fertilization, you simply discard embryos that test
positive for Tay-Sachs disease.
Can this disease be prevented or
minimized?
 1) Pre-natal genetic diagnosis: The parents can be
tested to see if they are carrier and if their offspring is
carrying both recessive alleles within 10 to 14 weeks.
The parents could then opt for abortion.
 2) Pre-implantation diagnosis: during in vitro
fertilization, you simply discard embryos that test
positive for Tay-Sachs disease.
 3) 3) Mate Selection: Some Orthodox Jewish groups
such as Dor Yeshorim perform a genetic screening
program that allows couple who test positive as carriers
can avoid conception.
Can this disease be prevented or
minimized?

 These three strategies are pretty drastic and indicate
that we may still be a while away from actual treatment
options for this rare deadly disease. As a result, these
strategies have presented us with two ethical dilemmas.
Ethical Dilemma?

 Does the current situation make an appropriate case for
abortion given that not all Tay-Sachs patients die in
infancy or childhood?
 In this particular case, is knowledge good, bad, or
ambivalent?
Ethical Dilemma?

 These are the important questions that we must address
and I leave them for you to decide the answer.
Thanks for participating!
Assorted Links and Works Cited
 http://www.cdc.gov/mmwr/preview/mmwrhtml/000383
93.htm

 http://omim.org/entry/272800
 http://link.springer.com/article/10.1007%2Fs00439003-1072-8
 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1685578/
 http://www.nature.com/mt/journal/v19/n6/full/mt20112
7a.html
 http://informahealthcare.com/doi/abs/10.1517/1354378
4.10.3.455
 http://www.jbc.org/content/279/14/13478.long
Assorted Links and Works Cited
 http://www.ninds.nih.gov/disorders/taysachs/taysachs.h
tm
 http://ghr.nlm.nih.gov/condition/tay-sachs-disease
 http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH000239
0/
 http://www.genome.gov/10001220
 http://commonhealth.wbur.org/2011/11/tay-sachshuman-trial
 http://newhoperesearch.org/GM2_gangliosidosis.html

More Related Content

What's hot

Psychology alzheimer's powerpoint
Psychology alzheimer's powerpointPsychology alzheimer's powerpoint
Psychology alzheimer's powerpoint
Brittany Rider
 
Tay Sachs
Tay SachsTay Sachs
Tay Sachszaudri
 
TAY-SACHS DISEASE
TAY-SACHS DISEASETAY-SACHS DISEASE
TAY-SACHS DISEASE
Sir. Stymass Kasty
 
Tay sach disease ppt 1
Tay sach disease ppt 1Tay sach disease ppt 1
Tay sach disease ppt 1
Farooq Gujjar
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's diseasecalvsh
 
Tay Sachs disease
Tay Sachs diseaseTay Sachs disease
Neuro degenerative disorders
Neuro degenerative disordersNeuro degenerative disorders
Neuro degenerative disorders
shahanaz ahamed
 
Pediatric autoimmune neuropsychiatric disorders (pandas)
Pediatric autoimmune neuropsychiatric disorders (pandas)Pediatric autoimmune neuropsychiatric disorders (pandas)
Pediatric autoimmune neuropsychiatric disorders (pandas)Prashant Makhija
 
Case history of spinal muscular atrophy
Case history of spinal muscular atrophy Case history of spinal muscular atrophy
Case history of spinal muscular atrophy mohammed sediq
 
Gaucher Disease
Gaucher DiseaseGaucher Disease
Gaucher Disease
fitango
 
Comprehensive overview on Wilson disease
Comprehensive overview on Wilson diseaseComprehensive overview on Wilson disease
Comprehensive overview on Wilson disease
Dr. Imdadul Magfur
 
Fabry Disease - Dr. Dina Ibrahim Sallam
Fabry Disease - Dr. Dina Ibrahim SallamFabry Disease - Dr. Dina Ibrahim Sallam
Fabry Disease - Dr. Dina Ibrahim Sallam
MNDU net
 
Digeorge syndrome
Digeorge syndromeDigeorge syndrome
Digeorge syndrome
Muzaffar khan
 
Alzheimer disease
Alzheimer diseaseAlzheimer disease
Alzheimer disease
visheshrohatgi
 
Lysosomal storage disorders
Lysosomal storage disordersLysosomal storage disorders
Lysosomal storage disorders
Rahul Arya
 
Subacute Sclerosing Panencephalitis
Subacute Sclerosing Panencephalitis Subacute Sclerosing Panencephalitis
Subacute Sclerosing Panencephalitis
Ade Wijaya
 
Epilepsy Syndromes
Epilepsy SyndromesEpilepsy Syndromes
Epilepsy Syndromes
dahmed hamed
 
Adrenoleukodystrophy
AdrenoleukodystrophyAdrenoleukodystrophy
Adrenoleukodystrophypfoschi
 

What's hot (20)

Psychology alzheimer's powerpoint
Psychology alzheimer's powerpointPsychology alzheimer's powerpoint
Psychology alzheimer's powerpoint
 
Tay Sachs
Tay SachsTay Sachs
Tay Sachs
 
TAY-SACHS DISEASE
TAY-SACHS DISEASETAY-SACHS DISEASE
TAY-SACHS DISEASE
 
Tay sach disease ppt 1
Tay sach disease ppt 1Tay sach disease ppt 1
Tay sach disease ppt 1
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's disease
 
Tay Sachs disease
Tay Sachs diseaseTay Sachs disease
Tay Sachs disease
 
Tay sachs DISEASE
 Tay sachs DISEASE Tay sachs DISEASE
Tay sachs DISEASE
 
Tay Sachs Disease
Tay Sachs DiseaseTay Sachs Disease
Tay Sachs Disease
 
Neuro degenerative disorders
Neuro degenerative disordersNeuro degenerative disorders
Neuro degenerative disorders
 
Pediatric autoimmune neuropsychiatric disorders (pandas)
Pediatric autoimmune neuropsychiatric disorders (pandas)Pediatric autoimmune neuropsychiatric disorders (pandas)
Pediatric autoimmune neuropsychiatric disorders (pandas)
 
Case history of spinal muscular atrophy
Case history of spinal muscular atrophy Case history of spinal muscular atrophy
Case history of spinal muscular atrophy
 
Gaucher Disease
Gaucher DiseaseGaucher Disease
Gaucher Disease
 
Comprehensive overview on Wilson disease
Comprehensive overview on Wilson diseaseComprehensive overview on Wilson disease
Comprehensive overview on Wilson disease
 
Fabry Disease - Dr. Dina Ibrahim Sallam
Fabry Disease - Dr. Dina Ibrahim SallamFabry Disease - Dr. Dina Ibrahim Sallam
Fabry Disease - Dr. Dina Ibrahim Sallam
 
Digeorge syndrome
Digeorge syndromeDigeorge syndrome
Digeorge syndrome
 
Alzheimer disease
Alzheimer diseaseAlzheimer disease
Alzheimer disease
 
Lysosomal storage disorders
Lysosomal storage disordersLysosomal storage disorders
Lysosomal storage disorders
 
Subacute Sclerosing Panencephalitis
Subacute Sclerosing Panencephalitis Subacute Sclerosing Panencephalitis
Subacute Sclerosing Panencephalitis
 
Epilepsy Syndromes
Epilepsy SyndromesEpilepsy Syndromes
Epilepsy Syndromes
 
Adrenoleukodystrophy
AdrenoleukodystrophyAdrenoleukodystrophy
Adrenoleukodystrophy
 

Similar to Implications of Tay-Sachs Disease: A Case Study for Public Knowledge

Cell biology review paper
Cell biology review paperCell biology review paper
Cell biology review paper
Brendan Kelemen
 
Genetic_Training for Medics
Genetic_Training for MedicsGenetic_Training for Medics
Genetic_Training for Medics
Arkar Linn Naing
 
Takayasu arteritis
Takayasu arteritisTakayasu arteritis
Takayasu arteritis
Ramachandra Barik
 
Identifying rare genetic variation in obsessive compulsive disorder
Identifying rare genetic variation in obsessive compulsive disorderIdentifying rare genetic variation in obsessive compulsive disorder
Identifying rare genetic variation in obsessive compulsive disorder
TÀI LIỆU NGÀNH MAY
 
Genetic Mutations
Genetic MutationsGenetic Mutations
Genetic Mutations
Sells Middle School
 
Genetics of dementia 2017
Genetics of dementia 2017Genetics of dementia 2017
Genetics of dementia 2017
Larry Baum
 
TOPIC-16-REVISION.pptx [Autosaved].pptx
TOPIC-16-REVISION.pptx [Autosaved].pptxTOPIC-16-REVISION.pptx [Autosaved].pptx
TOPIC-16-REVISION.pptx [Autosaved].pptx
YasmineHadiastriani2
 
Taysachs final
Taysachs finalTaysachs final
Taysachs final
monisha_gpb
 
Integrative Medicine and Experimental Pharmacogenomic Therapy in a Child with...
Integrative Medicine and Experimental Pharmacogenomic Therapy in a Child with...Integrative Medicine and Experimental Pharmacogenomic Therapy in a Child with...
Integrative Medicine and Experimental Pharmacogenomic Therapy in a Child with...
Sophia's Garden Foundation
 
Deletion 17q12 recurrent copy number variant ashadeep chandrareddy daniel d...
Deletion 17q12  recurrent copy number variant ashadeep  chandrareddy daniel d...Deletion 17q12  recurrent copy number variant ashadeep  chandrareddy daniel d...
Deletion 17q12 recurrent copy number variant ashadeep chandrareddy daniel d...
surabhisupraja
 
Genetic disorders 3
Genetic disorders 3Genetic disorders 3
Genetic disorders 3
Shahab Riaz
 
Tay-Sachs disease is caused by a mutation (abnormal change) in the g.pdf
Tay-Sachs disease is caused by a mutation (abnormal change) in the g.pdfTay-Sachs disease is caused by a mutation (abnormal change) in the g.pdf
Tay-Sachs disease is caused by a mutation (abnormal change) in the g.pdf
mukhtaransarcloth
 
Maths assignmenttt-
Maths assignmenttt-Maths assignmenttt-
Maths assignmenttt-
lohwenjun
 
The biochemistry of tay sachs disease
The biochemistry of tay sachs disease The biochemistry of tay sachs disease
The biochemistry of tay sachs disease
Dvane Coutinho
 
Genetic diseases tpe final - 2016
Genetic diseases   tpe final - 2016Genetic diseases   tpe final - 2016
Genetic diseases tpe final - 2016
Julia CHAPELAIN
 
Linked inheritance
Linked inheritanceLinked inheritance
Linked inheritance
Jeny Jose
 
Answer part a)According to the gene map of the wild type and the m.pdf
Answer part a)According to the gene map of the wild type and the m.pdfAnswer part a)According to the gene map of the wild type and the m.pdf
Answer part a)According to the gene map of the wild type and the m.pdf
appsmobileshoppe
 
Thalassemia in Children-How to manage .pptx
Thalassemia in Children-How to manage .pptxThalassemia in Children-How to manage .pptx
Thalassemia in Children-How to manage .pptx
MedicalSuperintenden19
 
Dan Geschwind, MD, PhD: Advances in Genetics 2016
Dan Geschwind, MD, PhD: Advances in Genetics 2016Dan Geschwind, MD, PhD: Advances in Genetics 2016
Dan Geschwind, MD, PhD: Advances in Genetics 2016
Semel Admin
 

Similar to Implications of Tay-Sachs Disease: A Case Study for Public Knowledge (20)

Cell biology review paper
Cell biology review paperCell biology review paper
Cell biology review paper
 
Genetic_Training for Medics
Genetic_Training for MedicsGenetic_Training for Medics
Genetic_Training for Medics
 
Tutorial01 (1)
Tutorial01 (1)Tutorial01 (1)
Tutorial01 (1)
 
Takayasu arteritis
Takayasu arteritisTakayasu arteritis
Takayasu arteritis
 
Identifying rare genetic variation in obsessive compulsive disorder
Identifying rare genetic variation in obsessive compulsive disorderIdentifying rare genetic variation in obsessive compulsive disorder
Identifying rare genetic variation in obsessive compulsive disorder
 
Genetic Mutations
Genetic MutationsGenetic Mutations
Genetic Mutations
 
Genetics of dementia 2017
Genetics of dementia 2017Genetics of dementia 2017
Genetics of dementia 2017
 
TOPIC-16-REVISION.pptx [Autosaved].pptx
TOPIC-16-REVISION.pptx [Autosaved].pptxTOPIC-16-REVISION.pptx [Autosaved].pptx
TOPIC-16-REVISION.pptx [Autosaved].pptx
 
Taysachs final
Taysachs finalTaysachs final
Taysachs final
 
Integrative Medicine and Experimental Pharmacogenomic Therapy in a Child with...
Integrative Medicine and Experimental Pharmacogenomic Therapy in a Child with...Integrative Medicine and Experimental Pharmacogenomic Therapy in a Child with...
Integrative Medicine and Experimental Pharmacogenomic Therapy in a Child with...
 
Deletion 17q12 recurrent copy number variant ashadeep chandrareddy daniel d...
Deletion 17q12  recurrent copy number variant ashadeep  chandrareddy daniel d...Deletion 17q12  recurrent copy number variant ashadeep  chandrareddy daniel d...
Deletion 17q12 recurrent copy number variant ashadeep chandrareddy daniel d...
 
Genetic disorders 3
Genetic disorders 3Genetic disorders 3
Genetic disorders 3
 
Tay-Sachs disease is caused by a mutation (abnormal change) in the g.pdf
Tay-Sachs disease is caused by a mutation (abnormal change) in the g.pdfTay-Sachs disease is caused by a mutation (abnormal change) in the g.pdf
Tay-Sachs disease is caused by a mutation (abnormal change) in the g.pdf
 
Maths assignmenttt-
Maths assignmenttt-Maths assignmenttt-
Maths assignmenttt-
 
The biochemistry of tay sachs disease
The biochemistry of tay sachs disease The biochemistry of tay sachs disease
The biochemistry of tay sachs disease
 
Genetic diseases tpe final - 2016
Genetic diseases   tpe final - 2016Genetic diseases   tpe final - 2016
Genetic diseases tpe final - 2016
 
Linked inheritance
Linked inheritanceLinked inheritance
Linked inheritance
 
Answer part a)According to the gene map of the wild type and the m.pdf
Answer part a)According to the gene map of the wild type and the m.pdfAnswer part a)According to the gene map of the wild type and the m.pdf
Answer part a)According to the gene map of the wild type and the m.pdf
 
Thalassemia in Children-How to manage .pptx
Thalassemia in Children-How to manage .pptxThalassemia in Children-How to manage .pptx
Thalassemia in Children-How to manage .pptx
 
Dan Geschwind, MD, PhD: Advances in Genetics 2016
Dan Geschwind, MD, PhD: Advances in Genetics 2016Dan Geschwind, MD, PhD: Advances in Genetics 2016
Dan Geschwind, MD, PhD: Advances in Genetics 2016
 

Recently uploaded

Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 

Recently uploaded (20)

Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 

Implications of Tay-Sachs Disease: A Case Study for Public Knowledge

  • 1. Implications of Tay-Sachs Disease: A Case Study for Public Knowledge By: Adam Green Wake Forest University Department of Biology
  • 2. What am I doing?  My goals are to explain:  What is Tay-Sachs Disease?
  • 3. What am I doing?  My goals are to explain:  What is Tay-Sachs Disease  How is it determined?
  • 4. What I am doing?  My goals are to explain:  What is Tay-Sachs Disease  How is it determined?  Who can have it and how lethal is it?
  • 5. What am I doing?  My goals are to explain:  What is Tay-Sachs Disease  How is it determined?  Who can have it and how lethal is it?  What are the treatment options?
  • 6. What am I doing?  My goals are to explain:  What is Tay-Sachs Disease  How is it determined?  Who can have it and how lethal is it?  What are the treatment options?  How can it be prevented?
  • 7. Patient Case Study and Ethics  Afterwards, I will present a mock patient case study and an ethical dilemma.
  • 8. Interactive Quiz Bowl  At the end of each section, there will be quiz questions.
  • 9. Interactive Quiz Bowl  You will work in teams and you will have two minutes to answer each question.
  • 10. Note of Warning  Before Beginning:  You should have a competent understanding of DNA, RNA, and the Central Dogma
  • 11. Note of Warning  Before Beginning:  You should have a competent understanding of DNA, RNA, and the Central Dogma  Genes and the types of mutations
  • 12. Notes of Warning  Before Beginning:  You should have a competent understanding of DNA, RNA, and the Central Dogma  Genes and the types of mutations  The endomembrane system
  • 13. Note of warning  Before Beginning:  You should have a competent understanding of DNA, RNA, and the Central Dogma  Genes and the types of mutations  The endomembrane system  The Plasma Membrane
  • 14. Notes of Warning  Before Beginning:  You should have a competent understanding of DNA, RNA, and the Central Dogma  Genes and the types of mutations  The endomembrane system  Plasma Membrane  Here are some helpful links:  http://www.ncbi.nlm.nih.gov/Class/MLACourse/Modules/ MolBioReview/slide_list.html  http://www.youtube.com/watch?v=UAaTEjYmxso  http://en.wikipedia.org/wiki/Cell_membrane
  • 15. Let’s Begin!  Please spilt into teams
  • 16. What is TaySachs Disease It is a lysosomal storage disorder due to genetic mutations in the HEX A gene.
  • 17. What is TaySachs Disease? • One common mutation is a 4 base insertion in the HEX A gene.
  • 18. What is TaySachs? As we know, this could change how the RNA is transcribed and the resultant protein.
  • 19. What is TaySachs Disease? And in fact, it does change the protein. The HEX A gene is responsible for the production of an enzyme(protein) called βhexsaminidase A that is responsible for breaking down fatty substances called GM2 gangliosides that can accumulate in our brains and spinal cords.
  • 20. What is TaySachs Disease? These enzymes(proteins) are made on ribosomes attached to the rough ER and sent to lysosomes that act as recycling centers to break down toxic substances such as fatty substances called GM2Gangliosidies that accumulate in our nervous system. Often lack of function of these enzymes results in death.
  • 21. What is TaySachs Disease? GM2 gangliosides contain a long hydrophobic tail that inserts itself into the plasma membrane of ganglion cells in neurons surrounding the retina of our eyes. Pictures: (top) Hexsaminidase with both alpha and beta subunits. Only the alpha subunit is involved in Tay-Sachs Disease. (bottom) is a depiction of a GM2-ganglioside.
  • 22. What is TaySachs Disease? They also contain acidic groups called head groups that stick above the plasma membrane and can be involved in cell-cell recognition as a result. While the exact function of GM2 Gangliosides is unknown, it has been suspected that they serve as an intermediate in the synthesis of more complex gangliosides needed for normal brain development.
  • 23. What is TaySachs Disease? This would explain why the enzyme HEX A cleaves part of the ganglioside and the absence of this enzyme results in improper brain development often culminating in death.
  • 24. What is TaySachs Disease? On another note, this disease is known as an autosomal recessive disorder
  • 25. What is TaySachs Disease? An autosomal recessive disorder means that the mutation in the HEXA gene exists in two alleles. Alleles are alternative form of a gene. Humans contain two sets of genes, one from their mother, and one from their father. The offspring must have two alleles, one from the mother and the father, in order for the disease to be expressed.
  • 26. What is TaySachs Disease? The actual enzyme activity required by β-hexosaminidase is very small in order to sufficiently break down GM2gangliosides. Thus, some individuals may only have one mutant copy of the HEXA gene. These individuals will have abnormally low enzyme activity levels, but still enough to break down fatty substances in your nervous system. They are called heterozygous carriers.
  • 27. What is TaySachs Disease? If two of these heterozygous carriers with abnormal enzyme levels mate, they have a 25% chance of having a child affected with Tay-Sachs Disease. This would mean that each parent has 1 mutant copy out of two (1/2) and the child has both copies; thus the probability is ½ x ½ = ¼ or 25% that the child will be affected. This is the basis for a recessive disorder. We see in this family tree, the offspring ratio is 3:1 and 25% chance of being affected.
  • 28. What is TaySachs Disease We can also illustrate this concept through a punnett square. Lets represent A as the normal HEX A allele(alternative form of gene) and a as the mutant allele that produces abnormal HEX A enzyme levels.
  • 29. What is TaySachs Disease? As you can see, when you cross two heterozygotes, you get a 25% chance of being affected.
  • 30. What is TaySachs Disease? Now, to further complicate matters, it is important to realize that more than 120 mutations have been found in the HEX A gene. These mutations vary in the amount of β-hexosaminidase they produce and thus lead to less severe forms of the disease.
  • 31. What is TaySachs Disease This leads to two subtypes of Tay- Sachs Disease: 1) Early-onset Infantile: the child possesses two mutant copies of the HEX A and produces no functional enzyme. This the most severe.
  • 32. What is TaySachs Disease? This leads to two subtypes TaySachs Disease: 1) Early-onset Infantile: the child possesses two mutant copies of the HEX A and produces none of the functional enzyme. This the most severe. 2) Late – onset adult: disease caused at times by compound heterozygosity that I will explain later. Patient has abnormal enzyme levels resulting in late-onset disease. The images present a young child with Tay-Sachs and an adult with Tay-Sachs
  • 33. Time for Quiz Questions!!  Ready your teams!
  • 34. Quiz Question 1  The following Base Sequence is the normal gene sequence: AGTCGTTAACCAG  Although the above sequence is not the HEX A gene, what mutational sequence below could be analogous to Tay-Sachs?  A. AGTCGTTCAACCAG  B. AGTCGTTCCAACCAG  C. AGTCGTTCCGGAACCAG  D. : AGTCGTTAACCAG
  • 35. Quiz Question 1  Time’s up!  Report your answers
  • 36. Quiz Question 1  The following Base Sequence is the normal gene sequence: AGTCGTTAACCAG  Although the above sequence is not the HEX A gene, what mutational sequence below could be analogous to TaySachs?  A. AGTCGTTCAACCAG  B. AGTCGTTCCAACCAG  C. AGTCGTTCCGGAACCAG  D. : AGTCGTTAACCAG THE ANSWER is C. A common mutation found in the HEX A gene can result from a 4 base pair insertion! Give yourself 2 points if you got it right. But note, that other mutations are also possible.
  • 37. Quiz Question 2  Brace yourselves!
  • 38. Quiz Question 2  If a male contains one mutant allele for the HEX A gene (Aa) and the female contains two normal alleles(AA), then what is the chance that they will have an offspring with Tay-Sachs? Hint: Draw a Punnett Square.  A. 75%  B. 60%  C. 25%  D. None of the above
  • 39. Quiz Question 2  Time’s up!  Report your Answers!
  • 40. Quiz Question 2  If a male contains one mutant allele for the HEX A gene (Aa) and the female contains two normal alleles(AA), then what is the chance that they will have an offspring with Tay-Sachs? Hint: Draw a Punnett Square.  A. 75%  B. 60%  C. 25%  D. None of the above THE ANSWER IS D. Tay-Sachs is a recessive disorder meaning that the offspring has to have two mutant alleles. Only one mutant allele is available. The answer should be 0%.
  • 41. Question 2: mathematics explained Here is an example of how this problem could be solved.  1) Make a punnett square. A A AA AA a  A Aa Aa 2)Perform data analysis. For example, we can say that 2/4 of the offspring or 50% will be heterozygous carriers. The remaining 50% will be homozygous dominant; thus, since there are no homozygous recessive offspring, we can say there is a 0% probability of the offspring having a recessive disease such as Tay- Sachs.
  • 42. Quiz Question 3  Brace yourselves!
  • 43. Question 3  The following blood test was conducted on a patient. The lab found his β-hexosaminidase levels to be operating at 15%. This means that 15% of the enzymes were functioning normally. Can we conclude the patient has Tay-Sachs?  A. Yes  B. No  C. Not sure yet.
  • 44. Question 3  Time is up!  Report your answers
  • 45. Question 3  The following blood test was conducted on a patient. The lab found his β-hexosaminidase levels to be operating at 15%. This means that 15% of the enzymes were functioning normally. Can we conclude the patient has Tay-Sachs?  A. Yes  B. No  C. Not sure yet.  THE ANSWER IS B. Remember that the enzyme only requires small amounts to function normally. This also ties in to our discussion about different mutations producing different activity levels. We will discuss more about “critical thresholds” in the next section.
  • 46. Tally your scores  Tally your points. The maximum score is 6 and the minimum score is 0.
  • 47. How is TaySachs Disease determined? Now that we know what this disease is. We need to know how is it determined in the lab.
  • 48. How is TaySachs Determined? Tay-Sachs is primarily determined by a blood test. An individual with a family history of Tay-Sachs can consult their physician and receive a simple blood test that measures βhexosaminidase levels.
  • 49. How is TaySachs Disease Determined? Remember Quiz Question 3? Well, it turns out that individuals affected with TaySachs Disease have between 0% activity to 10% activity. Infantile Tay-Sachs patients have 0%. Adult patients have an activity level between 510% to produce symptoms. Any amount greater than 10% will result in no symptoms.
  • 50. How is TaySachs Determined? Individuals with blood levels at or below this “critical threshold possess visible symptoms such as:
  • 51. How is TaySachs Disease Determined? Individuals with blood levels at or below this “critical threshold possess visible symptoms such as: 1) Cherry red- spot: results from the accumulation of GM2gangliosides that can block blood supply, disrupt a patient’s vision, and inhibit normal brain development. Prime indicator of Tay-Sachs.
  • 52. How is TaySachs Disease Determined? Individuals with blood levels at or below this “critical threshold possess visible symptoms such as: 1) Cherry red- spot: results from the accumulation of GM2gangliosides that can block blood supply and disrupt a patient’s vision. Prime indicator of Tay-Sachs. 2) In children, symptoms arise within 3 to 6 months. Children lose motor skills such as the ability to crawl.
  • 53. How is TaySachs Disease Determined? Individuals with blood levels at or below this “critical threshold possess visible symptoms such as: 1) Cherry red- spot: results from the accumulation of GM2gangliosides lipids that can block blood supply and disrupt a patient’s vision. Prime indicator of Tay-Sachs. 2) In children, symptoms arise within 3 to six months. Children lose motor skills such as the ability to crawl. 3) Eventually, affected individuals can experience seizures, paralysis, and loss of intellectual abilities due to their nerve cells dying.
  • 54. How is TaySachs Disease Determined? Individuals with blood levels at or below this “critical threshold possess visible symptoms such as: 1) Cherry red- spot: results from the accumulation of GM2gangliosides lipids that can block blood supply and disrupt a patient’s vision. Prime indicator of Tay-Sachs. 2) In children, symptoms arise within 3 to six months. Children lose motor skills such as the ability to crawl. 3) Eventually, affected individuals can experience seizures, paralysis, and loss of intellectual abilities due to their nerve cells dying. 4) Microscopic Analysis can also find the retinal neurons to be bloated from excess ganglioside storage. Pictures: The top image represents bloated retinal neurons from excess ganglioside storage due to hexosaminidase deficiency.
  • 55. How is TaySachs Determined? My next concern is how can a mutation or mutations in the Hex A gene be determined?
  • 56. How is TaySachs Determined? The answer can be solved through three related methodologies: 1) PCR
  • 57. How is TaySachs Disease Determined? The Answer can be solved through three related methodologies: 1) PCR 2) Gel Electrophoresis
  • 58. How is TaySachs Disease Determined? The Answer can be solved through three related methodologies: 1) PCR 2) Gel Electrophoresis 3) DNA Sequencing
  • 59. How is TaySachs Disease Determined? PCR stands for polymerase chain reaction. This is done to amplify a specific segment of a chromosome such as the HEX A gene or even a specific segment of the Hex A gene. The process can occur in 4 easy steps:
  • 60. How is TaySachs Disease Determined? PCR stands for polymerase chain reaction. This is done to amplify a specific segment of a chromosome such as the HEX A gene or even a specific segment of the Hex A gene. The process can occur in 4 easy steps: 1) RNA isolation: You have to isolate the RNA from your sample and covert it back to DNA using enzymes known as reverse transcriptases. This allows you to only amplify the region that is expressed.
  • 61. How is TaySachs Determined? PCR stands for polymerase chain reaction. This is done to amplify a specific segment of a chromosome such as the HEX A gene or even a specific segment of the Hex A gene. The process can occur in 4 easy steps: 1) RNA isolation: You have to isolate the RNA from your sample and covert it back to DNA using enzymes known as reverse transcriptases. This allows you to only amplify the region that is expressed. 2) You then apply heat to your DNA to pull the strands apart.
  • 62. How is TaySachs Determined? PCR stands for polymerase chain reaction. This is done to amplify a specific segment of a chromosome such as the HEX A gene or even a specific segment of the Hex A gene. The process can occur in 4 easy steps: 3) Anneal primers: attach thermostable DNA sequences to your DNA to begin the process of amplification
  • 63. How is TaySachs Determined? PCR stands for polymerase chain reaction. This is done to amplify a specific segment of a chromosome such as the HEX A gene or even a specific segment of the Hex A gene. The process can occur in 4 easy steps: 3) Anneal primers: attach thermostable base DNA sequence to your DNA to begin the process of amplification 4) Add a thermostable polymerase to attach to your primers and begin replication.
  • 64. How is TaySachs Determined? PCR stands for polymerase chain reaction. This is done to amplify a specific segment of a chromosome such as the HEX A gene or even a specific segment of the Hex A gene. The process can occur in 4 easy steps: 3) Anneal primers: attach thermostable base DNA sequence to your DNA to begin the process of amplification 4) Add a thermostable polymerase to attach to your primers and begin replication 5) Repeat to desired amplification. Picture: Diagram explaining PCR.
  • 65. How is TaySachs Determined? Now that you amplified DNA, you can place it on a gel and run an electric field through your DNA segment. The amplified DNA will show up on the gel and move along the gel against the negative electrode since DNA contains negatively charged phosphate groups.
  • 66. How is TaySachs Determined? Mutant Hex A can be the result of a 4 base pair insertion; thus, it would have more phosphate groups and move less along the gel than a normal HEX A DNA due to larger molecules getting stuck in the gel. Think of the gel as a sieve. The following picture is an example of data from a gel electrophoresis experiment. Smaller DNA fragments move farther than larger DNA fragments.
  • 67. How is TaySachs Determined? Since Tay-Sachs is caused by mutations, you can sequence the HEX A gene of a normal individual and an affected individual and see the DNA change. This is done in two ways: Sanger Sequencing and Cycle Sequencing via primers. Attached are two videos to watch that explains it in more detail: 1) http://www.dnalc.org/resour ces/animations/sangerseq.ht ml 2) http://www.dnalc.org/view/1 5923-Cycle-sequencing.html Picture on right depicts Fred Sanger who developed Sanger Sequencing. He recently died at the age of 95.
  • 68. QUIZ TIME!!  Now that you understand how mutations in the HEX A gene can be determined, you can answer these questions! Ready your troops!
  • 69. Quiz Question 4:  A mother reports to her physician that her 4 month year old just sits in one place for hours with no movement. She has to be the one to move him at all times. She suspects he may be paralyzed. What should the doctor suggest first in his/her diagnosis?  A. Look for observational clues such as a cherry red spot  B. Perform a Microscopy Analysis to search for distended neurons  C. Order a blood test to look for decreased βhexosaminidase activity levels.  D. Nothing. The woman is just a paranoid new mother.
  • 70. Question 4  Time’s up!!  Report your Answers!!
  • 71. Question 4  A mother reports to her physician that her 4 month year old just sits in one place for hours with no movement. She has to be the one to move him at all times. She suspects he may be paralyzed. What should the doctor suggest first in his diagnosis?  A. Look for observational clues such as a cherry red spot  B. Perform a Microscopy Analysis to search for distended neurons  C. Order a blood test to look for decreased β-hexosaminidase activity levels.  D. Nothing. The woman is just a paranoid new mother.  THE ANSWER IS A. While B and C are also possible, A is a prime indicator of Tay-Sachs and is the easiest and probably most convenient way to confirm Tay-Sachs.
  • 72. Quiz Question 5  Brace yourselves!!
  • 73. Question 5  What feature of DNA structure dictates our rationale that HEX A mutants with base pair insertions will result in shorter distances along a gel?  A. Phosphate groups.  B. Sugar groups  C. Base pairs.  D. acridine ligands
  • 74. Question 5  Time’s up!  Report your Answers!
  • 75. Question 5  What feature of DNA structure dictates our rationale that HEX A mutants with base pair insertions will have shorter distances along a gel?  A. Phosphate groups.  B. Sugar groups  C. Base pairs.  D. acridine ligands  THE ANSWER IS A. While The phosphates in the DNA backbone contain a negatively charged oxygen that cause the DNA to repel against the negative charged electrode, larger DNA fragments get stuck in the gel more than smaller fragments and thus move less.
  • 76. Tally your scores!  The most points awarded up to this point are 10 points(2 points per question).  The least points awarded are 0 points 
  • 77. How lethal is this disease? Now that we understand what Tay-Sachs disease is and how it can be determined, we still need to understand one other factor before we can do a patient case study. This last factor is lethality.
  • 78. How lethal is this disease? The most common form of TaySachs disease is infantile TaySachs. Symptoms normally appear around 3 to 6 months. The maximum longevity is sadly only about 4 years or simply a brief extent into early childhood.
  • 79. How lethal is this disease? Adult onset disease is more variable depending on the mutation and actual amount of β-hexosaminidase activity present in the cell.
  • 80. How lethal is this disease? Another factor for adult onset Tay-Sachs disease is the issue of compound heterozygosity that I mentioned previously.
  • 81. How lethal is this disease? Compound Heterozygosity is just weird. It occurs when an individual has two recessive allele mutations in the HEX A gene at different locations in the genome. This is indicative of the fact that there are over 120 mutations found in the HEX A gene. This can contribute to adult onset Tay-Sachs as a result.
  • 82. How lethal is this disease? Another aspect of lethality is the prevalence. According to recent studies, 1 out of every 300 people in the population is a heterozygous carrier for Tay-Sachs disease. However, for individuals who belong to a certain ethnic group known as the Ashkenazi Jews, the prevalence increases from 1 in 300 people to 1 in 30 people who will be a heterozygous carrier. Picture on the right depicts women of Ashkenazi Jewish heritage. They are genetically European.
  • 83. How lethal is this disease? The reason why the ratio is so much greater for Ashkenazi Jews is likely due to geographic distributions. A paper published in the American Journal of Human Genetics found the frequency of the HEX A mutation to be greater in geographically isolated regions with the highest frequencies in countries such as Russia, Lithuania, and other central and eastern European countries where the Ashkenazi Jews originated. As a result, the ratio is likely just bad luck. Figure. The geographic locations of the Ashkenazi Jews located in western and eastern Europe including Russia. Russia
  • 84. Quiz Time!!  Brace yourselves!!
  • 85. Quiz Question 6  Which of the following pieces of evidence favors random “bad luck” for the HEX A mutation in the Ashkenazi Jewish population?  A. The ratio for a carrier is 1 out of 30 instead of 1 out of 300.  B. High mutation frequency in one location and no frequnecy in other locations.  C. Heterozygous carriers are capable of producing subnormal enzyme activity levels to prevent symptoms from appearing.  D. Some mutations in the HEX A are more deadly than others.
  • 86. Quiz Question 6  Time’s up!!!  Report your Answers!
  • 87. Quiz Question 6  Which of the following pieces of evidence favor random founder effects over heterozygous advantage for the HEX A mutation in the Ashkenazi Jewish population?  A. The ratio for a carrier is 1 out of 30 instead of 1 out of 300.  B. High mutation frequency in one location and no frequency in other locations.  C. Heterozygous carriers are capable of producing subnormal enzyme activity levels to prevent symptoms from appearing.  D. Some mutations in the HEX A are more deadly than others.  THE ANSWER IS B. Random founder effects occur from genetic breeding/sampling in isolated populations over long timespans.
  • 88. Case Study of Alex  Now that you understand the basis of Tay-Sachs Disease  We can examine a mock case study.  Let’s begin
  • 89. Meet Alex  Alex, short for Alexander, is from Russia with two Russian parents. They are part of the Ashkenazi Jewish heritage.
  • 90. Meet Alex  Alex, short for Alexander, is from Russia with two Russian parents. They are part of the Ashkenazi Jewish heritage.  He is 3 months old.
  • 91. Meet Alex  Alex, short for Alexander, is from Russia with two Russian parents. They are part of the Ashkenazi Jewish heritage.  He is 3 months old.  Alex is the first child of his parents.
  • 92. Meet Alex  Alex, short for Alexander, is from Russia with two Russian parents. They are part of the Ashkenazi Jewish heritage.  Alex is 3 months old.  Alex is the first child of his parents  A physician observed an eye abnormality called a cherry red spot through a simple eye examination.
  • 93. Quiz Question 7  Brace yourselves!
  • 94. Quiz Question 7  What should the doctor order based on these evaluations?  A. blood test to measure α-hexosaminidase levels.  B. motor skills test.  C. Microscopy analysis of bloated nerve cells.  D. blood test to measure β- hexosaminidase levels.
  • 95. Quiz Question 7  Time’s up!  Report your Answers!
  • 96. Quiz Question 7  What should the doctor order based on these evaluations?  A. blood test to measure α-hexosaminidase levels.  B. motor skills test.  C. Microscopy analysis of bloated nerve cells.  D. blood test to measure β- hexosaminidase levels.  THE BEST ANSWER IS D. Currently, the evidence is strong for Tay-Sachs Disease, but we need to see if the enzyme activity levels are below the “critical threshold” levels.
  • 97. Tally your scores!  The maximum points possible are now 14 points.
  • 98. Alex  The Blood test results are in and the enzyme activity levels are immeasurable which indicates infantile TaySachs Disease.
  • 99. Quiz Question 8  Brace yourselves!
  • 100. Quiz Question 8  What should the doctor’s next recommendation be? A. Order the lab to characterize the mutation through PCR and gel electrophoresis B. Nothing. The blood test is enough evidence. C. Contact a genetic counselor D. Re-run the blood test to confirm accuracy.
  • 101. Quiz Question 8  Time’s up!  Report your answers
  • 102. Quiz Question 8  What should the doctor’s next recommendation be? A. Order the lab to characterize the mutation through PCR and gel electrophoresis B. Nothing. The blood test is enough evidence. C. Contact a genetic counselor D. Re-run the blood test to confirm accuracy. THE ANSWER IS A. While one blood test is good evidence, it does not tell us anything about the genetics of the individual. Thus, it does not inform us if a mutation is actually present.
  • 103. Quiz Question 9  The results are in:
  • 104. Quiz Question 9  The results are in:  PCR and gel electrophoresis confirm shorter PCR products indicating a base insertion.
  • 105. Quiz Question 9  The results are in:  PCR and gel electrophoresis confirm shorter PCR products indicating a base insertion.  DNA Sequencing confirms a 4 base addition for the HEX A gene.
  • 106. Quiz Question 8  The results are in:  PCR and gel electrophoresis confirm shorter PCR products indicating a base insertion.  DNA Sequencing confirms a 4 base addition for the HEX A gene.  This agrees with the blood test and observational clues to confirm Tay-Sachs Disease.
  • 107. Quiz Question 9  Now Brace yourselves!
  • 108. Quiz Question 9 What are the possible treatment options given this new diagnosis? A. Gene therapy approaches that engineer viruses which will turn the nerve cells into “micro factories” that produce β-hexosaminidase. B. Developing synthetic chaperones that guide the βhexosaminidase to fold into its native 3D structure. C. Replace the β-hexsaminidase enzyme just like diabetics undergo insulin replacement. D. Use alternative enzymes that catabolize GM2gangliosides
  • 109. Quiz Question 9  Time’s up  Report your answers!
  • 110. Quiz Question 9 Patient X =  The correct answer is none of the above. All of the answer choices exhibit examples of positive research results, but they are all still a long away from actual clinical treatment. So for now, Tay-Sachs disease, in particular the more common Infantile TaySachs Disease is a genetic death sentence that will shut down a child’s nervous system before he/she reaches kindergarden.
  • 111. Quiz Question 9  As a result, when it comes to Tay-Sachs Disease, especially infantile Tay-Sachs, no one is a winner and that’s why no points are awarded for this question.
  • 112. Quiz Question 9  As a result, when it comes to Tay-Sachs Disease, especially infantile Tay-Sachs, no one is a winner and that’s why no points are awarded for this question.  Since Alex is afflicted with this disease, he will die and his parents will be left childless.
  • 113. Can this disease be prevented or minimized?  1) Pre-natal genetic diagnosis: The parents can be tested to see if they are carriers and if their offspring is carrying both recessive alleles within 10 to 14 weeks. The parents could then opt for abortion.
  • 114. Can this disease be prevented or minimized?  1) Pre-natal genetic diagnosis: The parents can be tested to see if they are carrier and if their offspring is carrying both recessive alleles within 10 to 14 weeks. The parents could then opt for abortion.  2) Pre-implantation diagnosis: during in vitro fertilization, you simply discard embryos that test positive for Tay-Sachs disease.
  • 115. Can this disease be prevented or minimized?  1) Pre-natal genetic diagnosis: The parents can be tested to see if they are carrier and if their offspring is carrying both recessive alleles within 10 to 14 weeks. The parents could then opt for abortion.  2) Pre-implantation diagnosis: during in vitro fertilization, you simply discard embryos that test positive for Tay-Sachs disease.  3) 3) Mate Selection: Some Orthodox Jewish groups such as Dor Yeshorim perform a genetic screening program that allows couple who test positive as carriers can avoid conception.
  • 116. Can this disease be prevented or minimized?  These three strategies are pretty drastic and indicate that we may still be a while away from actual treatment options for this rare deadly disease. As a result, these strategies have presented us with two ethical dilemmas.
  • 117. Ethical Dilemma?  Does the current situation make an appropriate case for abortion given that not all Tay-Sachs patients die in infancy or childhood?  In this particular case, is knowledge good, bad, or ambivalent?
  • 118. Ethical Dilemma?  These are the important questions that we must address and I leave them for you to decide the answer.
  • 120. Assorted Links and Works Cited  http://www.cdc.gov/mmwr/preview/mmwrhtml/000383 93.htm  http://omim.org/entry/272800  http://link.springer.com/article/10.1007%2Fs00439003-1072-8  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1685578/  http://www.nature.com/mt/journal/v19/n6/full/mt20112 7a.html  http://informahealthcare.com/doi/abs/10.1517/1354378 4.10.3.455  http://www.jbc.org/content/279/14/13478.long
  • 121. Assorted Links and Works Cited  http://www.ninds.nih.gov/disorders/taysachs/taysachs.h tm  http://ghr.nlm.nih.gov/condition/tay-sachs-disease  http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH000239 0/  http://www.genome.gov/10001220  http://commonhealth.wbur.org/2011/11/tay-sachshuman-trial  http://newhoperesearch.org/GM2_gangliosidosis.html